Infusion of Mesenchymal Stromal Cells can Aid Hematopoietic Recovery Following Allogeneic Hematopoietic Stem Cell Myeloablative Transplant: A Pilot Study
- 1 November 2009
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 18 (9), 1247-1252
- https://doi.org/10.1089/scd.2009.0029
Abstract
Mesenchymal stromal cells (MSCs) are important in the support of hematopoiesis. In this pilot study, we evaluated the safety and efficiency of donor-expanded MSC infusion after allogeneic hematopoietic stem cell transplantation (HSCT) in six patients with poor hematopoietic recovery. MSCs were infused without HSC and without conditioning at a dose of 1 × 106/kg weight. Two patients displayed rapid hematopoietic recovery (days 12 and 21), and four patients showed no response. The two patients who showed hematopoietic recovery were in first complete remission (CR1) compared to the other heavily pretreated patients. There were no toxic side effects linked to MSC infusion. One patient developed cytomegalovirus (CMV) reactivation 12 days following the MSC infusion and died from CMV disease. We found that infusion of MSCs without HSC co-infusion can restore medullary function in some patients with poor hematopoietic recovery. Our data suggest that patients with a less damaged stroma could benefit from this approach.Keywords
This publication has 37 references indexed in Scilit:
- Immunomodulatory properties of mesenchymal stromal cellsBlood, 2007
- Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cellsLeukemia, 2007
- Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host DiseaseTransplantation, 2006
- Hematopoietic Stem-Cell TransplantationThe New England Journal of Medicine, 2006
- Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individualBone Marrow Transplantation, 2006
- Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartmentBlood, 2006
- Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy PatientsTransplantation and Cellular Therapy, 2005
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsExperimental Hematology, 2003
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999